Bio

As leader of the firmwide emerging companies and venture capital (ECVC) practice, Jeffrey Bodle counsels emerging companies and other innovative high-growth companies at every stage of their business lifecycle—including in mergers and acquisitions (M&A); angel, venture capital, and growth equity financings; IPOs; securities offerings and compliance; corporate partnering; joint ventures; formation advice; and other strategic and outside general counsel matters. Jeff also represents seed, venture capital, growth equity, private equity, institutional, and corporate venture capital (CVC) investors in financing, M&A, and portfolio company transactions. Jeff focuses primarily in the healthcare, life sciences, retail/e-commerce/consumer products, technology, and venture capital and private equity industries. Jeff nurtures entrepreneurs and startup clients by reviewing their business plans, helping identify appropriate financing sources, and connecting them to various emerging company and venture capital communities. He also provides legal and strategic advice on choice of entity and formation issues, equity and incentive structures, equity financing, venture capital, growth equity and debt financing structures, and the execution of growth strategies, including M&A. He counsels boards of directors and senior management on corporate governance, securities compliance, and IP matters and offers advice on exit and liquidity strategies, including secondary transactions and growth equity recapitalizations; preparing for and executing a sale transaction, M&A transaction, or IPO; or transitioning from a private to a public company. An active member of the Philadelphia, Pennsylvania and Mid-Atlantic startup, emerging companies, and venture capital communities, Jeff speaks regularly on startup, emerging companies, and venture capital topics and serves as a coach and judge at investor and venture fairs and business plan competitions.